PROTAGONIST THERAPEUTICS, INC. (PTGX) Net income 2016–2025
PROTAGONIST THERAPEUTICS, INC. (PTGX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$130.1MFY2025 · since FY2016: -$37.2M → -$130.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$130.1M | -147.3% |
| FY2024 | $275.2M | +448.5% |
| FY2023 | -$79.0M | +38.0% |
| FY2022 | -$127.4M | -1.5% |
| FY2021 | -$125.6M | -89.8% |
| FY2020 | -$66.2M | +14.3% |
| FY2019 | -$77.2M | -98.3% |
| FY2018 | -$38.9M | -5.3% |
| FY2017 | -$37.0M | +0.6% |
| FY2016 | -$37.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice